A history of the development of narcotic antagonists for the treatment of narcotic addiction.
D000818:Animals; D003496:Cyclazocine / Q000627:therapeutic use; D004361:Drug Tolerance; D005059:Euphoria / Q000187:drug effects; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics; D011957:Receptors, Opioid / Q000187:drug effects; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D009292:Narcotic Antagonists; D009294:Narcotics; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone; D003496:Cyclazocine